Northwest Biotherapeutics completes private placement

On March 17, cancer vaccine company Northwest Biotherapeutics Inc. (OTCQB:NWBO) raised $7.5 million through the sale of 28.8 million shares at $0.26 in a registered direct offering. Investors also re...